Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Internal Medicine

Pediatrics

Psychiatry And Mental Health

Experimental And Cognitive Psychology

Show all topics

DOI

10.1016/s0140-6736(17)30060-0